Variant is a biotechnology company that develops innovative products in the ophthalmology sector. Variant aims to provide the pharmaceutical industry with solid proof-of-concept data to enable the clinical development of therapeutic strategies intended for rare visual diseases. The company has several scientific collaborations specialized in genome analysis, production and administration of AAV vectors, and human retinal organoids. Our associated partners are well-positioned to test therapies for dominant and recessive retinal dystrophy forms, notably orphan diseases, such as congenital Leber Amaurosis, cone-rod dystrophies, and retinitis pigmentosa. Variant’s leading preclinical portfolio has a diversified risk profile: the company specializes in the use of “transcription factor” genes, which intervene very early in the development of photoreceptors to relaunch the differentiation of cones and rods in the retina.
| Website | https://www.variant.paris/ |
| Employees | 4 (4 on RocketReach) |
| Founded | 2017 |
| Address | 9 rue de L'éperon, Paris, Île-de-France 75006, FR |
| Industry | Biotechnology Research |
| Keywords | Ophthalmology, Biotechnology, Ocular Health, Eye Disease, Ophthalmic Products, Therapeutics, Eye Care, Innovative Therapies, Pharmaceutical, Drug Development, Vision Science, Treatment Development, Drug Discovery, Vision Research, Clinical Trials, Biopharma, Clinical Research, Medical Technology, Life Sciences, Healthcare |
Looking for a particular VARIANT employee's phone or email?
VARIANT Questions
Denis Cayet is the CEO de VARIANT of VARIANT.
4 people are employed at VARIANT.
VARIANT is based in Paris, Île-de-France.
Top VARIANT Employees
-
Denis Cayet
CEO de VARIANT at VARIANT
Île-de-France, France12 -
1
Related Companies
